The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Edesa anticipates topline results could be available within as few as 12 to 18 months following regulatory clearance by the FDA. Health Canada has previously granted approval to initiate this Phase 2 ...

Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade ...

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...